Core Viewpoint - The company, Yiduoli (300381.SZ), is actively engaged in the development and production of aquaculture feed additives, including enzyme preparations and plant extracts, and has established a collaboration with the Chinese Academy of Agricultural Sciences to enhance the gut health of aquatic animals [1][3]. Group 1 - The company currently offers products such as aquaculture enzyme preparations, plant extracts, and other feed additives [1]. - The collaboration with the Chinese Academy of Agricultural Sciences has resulted in significant advancements in improving the gut health of aquatic animals [1]. - The company plans to continue its business in aquaculture enzyme preparations and other related feed additives [1].

Core Viewpoint - The company, Yiduoli (300381.SZ), is actively engaged in the production of aquaculture enzyme preparations, plant extracts, and other feed additives, emphasizing its collaboration with the Chinese Academy of Agricultural Sciences to enhance the gut health of aquatic animals [1] Group 1 - The company offers a range of products including aquaculture enzyme preparations and plant extracts [1] - Collaboration with the Chinese Academy of Agricultural Sciences has resulted in successful product implementation [1] - The company aims to continue its focus on aquaculture enzyme preparations and other feed additive businesses [1]

Core Insights - The phytic acid enzyme market is experiencing significant growth, primarily driven by increased demand in the feed industry, especially after the ban on antibiotics in animal feed in China in 2020, positioning phytic acid enzymes as ideal alternatives [1][7] - China's annual production of phytic acid enzymes has significantly increased, from 43,200 tons in 2015 to an expected 120,600 tons by 2024, indicating a robust growth trajectory [1][8] - The global phytic acid enzyme market is projected to grow from $513 million in 2023 to $822 million by 2029, with a compound annual growth rate (CAGR) of 8.2% [6] Industry Overview - Phytic acid enzymes belong to the class of phosphoric monoester hydrolases and are crucial for enhancing the bioavailability of minerals in plant-based feeds by breaking down phytic acid [2] - The industry has evolved through three stages: initial development in the 1990s, rapid growth from 2001 to 2012, and a mature phase from 2013 onwards, with domestic products replacing imports and achieving international technical standards [3][4] Industry Chain - The upstream of the phytic acid enzyme industry includes raw materials such as wheat, barley, and microorganisms, while the downstream applications span food, pharmaceutical, and feed industries [5] - The feed industry is the largest application area for phytic acid enzymes, driven by the need to improve feed efficiency and reduce costs, with a notable increase in China's feed production reaching 250.7 million tons in the first nine months of 2025, up 6.4% year-on-year [5][6] Competitive Landscape - The global phytic acid enzyme market is highly competitive, with companies like Novozymes, DuPont, and DSM holding significant market shares due to their technological advantages and patent protections [8] - Chinese companies such as Blue Horizon Biotechnology, Yidali, and Xinghuo Technology are emerging as strong competitors, gradually capturing high-end market segments [8] Development Trends - Technological innovation is a key driver for the industry, with advancements in enzyme production and purification methods expected to enhance yield and efficiency [10] - The application of phytic acid enzymes is expanding beyond traditional uses in poultry and pig feed to include aquaculture and organic agriculture, indicating new growth opportunities [11] - Environmental sustainability is becoming increasingly important, with stricter regulations prompting phytic acid enzyme companies to enhance their eco-friendly practices and production processes [12]

Core Points - The Shanghai Composite Index is at 4017.68 points, above the six-month moving average, with a slight decline of 0.29% [1] - A total trading volume of A-shares reached 15648.48 billion yuan today [1] - 113 A-shares have surpassed the six-month moving average, with notable stocks showing significant deviation rates [1] Summary by Category Stock Performance - The top three stocks with the highest deviation rates from the six-month moving average are: - Electric Investment and Financing (9.07%) - Jie Rong Technology (7.54%) - Annie Shares (4.91%) [1] - Other stocks with smaller deviation rates that have just crossed the six-month line include: - Baoland, Zhongnong Lihua, and Subote [1] Trading Data - The trading performance of selected stocks includes: - Electric Investment and Financing: +9.94% with a turnover rate of 2.09% - Jie Rong Technology: +10.00% with a turnover rate of 8.20% - Annie Shares: +6.44% with a turnover rate of 18.47% [1] - Additional stocks with notable performance include: - Yahua Electronics: +6.29% - Zhonglu Shares: +7.08% - Jinlihua Electric: +4.81% [1]

Core Viewpoint - Yidoli is a leading domestic producer of biological enzyme preparations and steroid hormone raw materials, with strong R&D capabilities and a complete industry chain advantage [1] Group 1: Business Overview - Yidoli was established on September 3, 1991, and listed on the Shenzhen Stock Exchange on January 28, 2014, with its registered and office address in Zhuhai, Guangdong Province [1] - The main business includes R&D, production, sales, and services of biological enzyme preparations, steroid hormone raw materials, plant extracts, and animal nutrition and health products, providing comprehensive biotechnology solutions [1] Group 2: Financial Performance - For Q3 2025, Yidoli's operating revenue was 613 million yuan, ranking 27th out of 47 in the industry, significantly lower than the industry leader, Pro Pharmaceutical, which had 7.764 billion yuan, and the second place, Nentek Technology, with 7.13 billion yuan [2] - The net profit for the same period was 19.49 million yuan, ranking 34th in the industry, with a notable gap compared to the industry leader, Zhejiang Pharmaceutical, at 867 million yuan, and Pro Pharmaceutical at 700 million yuan [2] Group 3: Financial Ratios - As of Q3 2025, Yidoli's debt-to-asset ratio was 8.95%, down from 9.68% year-on-year, significantly lower than the industry average of 27.75%, indicating strong solvency [3] - The gross profit margin for the same period was 46.51%, slightly up from 46.43% year-on-year, and higher than the industry average of 35.38%, reflecting strong profitability [3] Group 4: Executive Compensation - Chairman Chen Shaomei's salary for 2024 was 1.1986 million yuan, an increase of 1,900 yuan from 2023 [4] - President Zhou Derong's salary for 2024 was 924,800 yuan, an increase of 2,100 yuan from 2023 [4] Group 5: Shareholder Information - As of September 30, 2025, the number of A-share shareholders was 20,100, with an average holding of 24,400 circulating A-shares, showing no change from the previous period [5] - Among the top ten circulating shareholders, the Guotai Zhongzheng Livestock Breeding ETF ranked as the fourth largest, holding 8.6164 million shares, an increase of 3.0406 million shares from the previous period [5]

Core Insights - Yiduoli (300381.SZ) reported its Q3 2025 results, highlighting a significant increase in institutional investor holdings, which now account for 31.44% of the total shares outstanding [1] Institutional Holdings - As of October 28, 2025, three institutional investors disclosed their holdings in Yiduoli A-shares, totaling 154 million shares [1] - The institutional investors include Zhuhai Jindadi Investment Co., Ltd., Zheshang Bank Co., Ltd. - Guotai Zhongzheng Livestock Breeding ETF, and Zhuhai Juyi Fund Management Co., Ltd. - Juyi Yuer No. 2 Private Securities Investment Fund [1] - The overall institutional holding percentage increased by 0.85 percentage points compared to the previous quarter [1] Public Fund Holdings - One public fund, Guotai Zhongzheng Livestock Breeding ETF, increased its holdings during this period, with an increase percentage of 0.62% [1] - Twelve public funds that were not disclosed in the previous quarter include notable names such as China Merchants Zhongzheng Livestock Breeding ETF and Ping An Zhongzheng Livestock Breeding ETF [1]

Core Insights - The company reported a revenue of 613 million yuan for the first three quarters of 2025, representing a year-on-year growth of 0.77% [1] - The net profit attributable to shareholders decreased by 57.47% to 18.2044 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 33.65% to 18.7673 million yuan [1] - The basic earnings per share were 0.0371 yuan [1]

Core Viewpoint - Yiduoli (300381) announced that the company and its subsidiaries do not have overdue debts related to guarantees, are not involved in any litigation guarantees, and have not been judged to bear any liabilities due to guarantees, indicating a stable financial position [1] Group 1 - The company confirmed the absence of overdue debts corresponding to guarantees [1] - There are no litigation-related guarantees involving the company [1] - The company has not been subject to any judgments resulting in liability due to guarantees [1]

Group 1 - Company Yiduoli reported Q3 performance with revenue of approximately 613 million yuan, an increase of 0.77% year-on-year [1] - Net profit attributable to shareholders was approximately 18.2 million yuan, a decrease of 57.47% year-on-year [1] - Basic earnings per share were 0.0371 yuan, down 57.5% compared to the previous year [1] Group 2 - As of the report, the market capitalization of Yiduoli is 3.4 billion yuan [2]

Group 1 - Company Yiduoli (SZ 300381) announced on October 28 that its 15th meeting of the 8th board of directors was held via communication, where the proposal for the "2025 Q3 Report" was reviewed [1] - For the year 2024, Yiduoli's revenue composition is as follows: 83.57% from the biomanufacturing industry, 15.71% from the bio-agriculture and animal husbandry industry, and 0.72% from other industries [1] - As of the report date, Yiduoli's market capitalization is 3.4 billion yuan [1] Group 2 - The A-share market has surpassed 4000 points, marking a significant resurgence after a decade of stagnation, with technology leading the market's transformation into a new "slow bull" pattern [1]